Pamela Donner

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A

David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis and Structure−Activity Relationships of 2-Pyridones:  A Novel Series of Potent DNA Gyrase Inhibitors as Antibacterial Agents

Qun Li, Daniel T. W. Chu, Akiyo Claiborne et al. · Journal of Medicinal Chemistry · 1996 · 75 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Inhibitors of HCV NS5B polymerase: synthesis and structure–activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines

John K. Pratt, Pamela Donner, Keith F. McDaniel et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 40 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +12

953 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072

G. V. Koev, Rubina Mondal, Jill Beyer et al. · Journal of Hepatology · 2009 · 10 citations · Full text

Life Sciences, Genetics, Molecular Biology +9

The synthesis and in vitro antibacterial activity of conformationally restricted quinolone antibacterial agents

Curt S. Cooper, Michael D. Tufano, Pamela Donner et al. · Bioorganic & Medicinal Chemistry · 1996 · 10 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14